Organogenesis

Scope & Guideline

Advancing the Frontiers of Developmental Biology.

Introduction

Explore the comprehensive scope of Organogenesis through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Organogenesis in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1547-6278
PublisherTAYLOR & FRANCIS INC
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2004 to 2005, from 2007 to 2024
AbbreviationORGANOGENESIS / Organogenesis
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal 'Organogenesis' focuses on the intricate processes of organ development and regeneration, with an emphasis on stem cell biology, tissue engineering, and regenerative medicine. It aims to bridge the gap between basic science and clinical applications, promoting innovative methodologies and approaches in organogenesis research.
  1. Stem Cell Biology and Tissue Regeneration:
    The journal publishes research on the role of stem cells in organ development and regeneration, exploring how these cells can be harnessed for therapeutic purposes.
  2. Organ-on-a-Chip Technologies:
    A significant focus is on the development and application of organ-on-a-chip platforms, which mimic human organ systems for disease modeling and drug testing.
  3. Mechanisms of Organ Development:
    Research articles often delve into the molecular and cellular mechanisms underlying organogenesis, including signaling pathways and gene expression profiles.
  4. Clinical Applications and Therapeutics:
    The journal emphasizes translational research, showcasing studies that connect basic organogenesis research to potential clinical therapies, particularly in organ transplantation and regenerative medicine.
  5. Disease Modeling and Therapeutics:
    There is a consistent focus on using organoid and stem cell technologies to model diseases and develop novel therapeutic strategies.
The journal 'Organogenesis' has shown a dynamic evolution in its focus areas, with several emerging themes gaining traction in recent publications. These reflect the latest advancements in research methodologies and clinical applications.
  1. Organoids and Organoids-On-A-Chip:
    There is a marked increase in studies utilizing organoids and organ-on-a-chip technologies, reflecting a growing interest in these innovative platforms for disease modeling and drug testing.
  2. Stem Cell Therapeutics:
    Research on the therapeutic applications of various stem cell types, particularly in regenerative medicine and organ transplantation, has seen a notable rise, indicating a trend towards clinical applications.
  3. Exosome and Cell-Derived Therapies:
    Emerging studies are focusing on the role of exosomes and cell-derived factors in therapeutic contexts, particularly in organ injury and regeneration, highlighting their potential as novel treatment strategies.
  4. Molecular Mechanisms in Regeneration:
    An increasing number of papers are dedicated to understanding the molecular mechanisms that govern regeneration, including gene expression and signaling pathways, which are crucial for developing targeted therapies.
  5. Precision Medicine Approaches:
    There is a growing emphasis on precision medicine, particularly in the context of cancer and liver disease, showcasing a shift towards personalized therapeutic strategies based on individual patient profiles.

Declining or Waning

While 'Organogenesis' continues to thrive in many areas, certain themes have seen a decline in prominence over recent years. This section highlights these waning scopes, indicating a potential shift in research focus within the journal.
  1. Pathological Mechanisms of Rare Diseases:
    Research focusing on the organogenesis aspects of rare diseases has decreased, suggesting a shift towards more prevalent conditions and broader therapeutic applications.
  2. Historical Perspectives on Organ Development:
    Papers that provide historical or retrospective analyses of organ development processes are less frequent, indicating a move towards contemporary and applied research.
  3. Basic Embryology Studies:
    There appears to be a waning interest in traditional embryological studies without direct application to regenerative or therapeutic contexts, as the journal prioritizes studies with clear translational potential.

Similar Journals

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Fostering Collaboration in Pathology and Molecular Science
Publisher: WILEYISSN: 0959-9673Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

DIFFERENTIATION

Fostering Innovation in Cancer and Cell Biology
Publisher: ELSEVIER SCI LTDISSN: 0301-4681Frequency: 6 issues/year

DIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.

CELLS TISSUES ORGANS

Unlocking the Secrets of Anatomy and Histology.
Publisher: KARGERISSN: 1422-6405Frequency: 6 issues/year

CELLS TISSUES ORGANS is a renowned academic journal published by KARGER, focusing on pivotal research within the fields of Anatomy and Histology. Based in Switzerland, this journal has been disseminating influential scientific findings since 1889, contributing to our understanding of cellular structures and tissue functionality. With a current impact factor that places it in the Q2 quartile for both disciplines, it serves as a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions in these areas. The journal embraces an Open Access model, ensuring that high-quality, peer-reviewed articles are freely available, thus enhancing visibility and accessibility of critical research. As it continues to foster scholarly communication and innovation up to 2024, CELLS TISSUES ORGANS plays a crucial role in shaping the future of biological sciences and medical research.

Regenerative Medicine

Unleashing Potential in Tissue Engineering
Publisher: TAYLOR & FRANCIS LTDISSN: 1746-0751Frequency: 12 issues/year

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.

DEVELOPMENT GROWTH & DIFFERENTIATION

Exploring the Mechanisms of Life’s Complexities
Publisher: WILEYISSN: 0012-1592Frequency: 9 issues/year

DEVELOPMENT GROWTH & DIFFERENTIATION, published by Wiley, stands as a vital journal in the realms of Cell Biology, Developmental Biology, and Medicine. With an ISSN of 0012-1592 and E-ISSN of 1440-169X, this esteemed journal has been a key player in the scientific community since its inception in 1969, continuing to contribute significantly to the understanding of developmental processes and mechanisms underlying growth and differentiation. Ranked Q3 in Cell Biology and Developmental Biology, and Q2 in miscellaneous aspects of Medicine as of 2023, the journal provides a platform for high-quality research articles, reviews, and critical insights that foster academic discourse in these vital fields. Although currently not available as open access, the journal ensures the availability of essential research to its global readership, facilitating collaboration and innovation. Researchers, professionals, and students alike will find DEVELOPMENT GROWTH & DIFFERENTIATION to be an invaluable resource for advancing knowledge and driving forward the scientific inquiry into the intricacies of biological development.

Cells & Development

Fostering High-Impact Research in Developmental Biology
Publisher: ELSEVIERISSN: 2667-2901Frequency: 4 issues/year

Cells & Development is a premier journal published by Elsevier, dedicated to advancing the field of Developmental Biology. With an ISSN of 2667-2901 and an impressive Q2 ranking in its category for 2023, the journal endeavors to provide a platform for high-quality research articles that explore cellular mechanisms, developmental processes, and molecular interactions that underpin growth and differentiation. Based in the Netherlands, Cells & Development not only emphasizes the importance of innovative experimental approaches but also encourages interdisciplinary contributions that bridge the gap between basic and applied science. As an Open Access publication, it ensures that research findings are readily accessible to a global audience, significantly enhancing visibility and impact. The journal's commitment to scholarly excellence makes it an essential resource for researchers, professionals, and students aiming to contribute to the dynamic field of developmental biology.

DNA AND CELL BIOLOGY

Exploring the Frontiers of Molecular Discovery
Publisher: MARY ANN LIEBERT, INCISSN: 1044-5498Frequency: 12 issues/year

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Fostering Scientific Dialogue in Cellular Research
Publisher: SPRINGERISSN: 1071-2690Frequency: 10 issues/year

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, published by SPRINGER, is a pivotal journal in the fields of cell biology and developmental biology, focusing on in vitro studies that enhance our understanding of animal cellular mechanisms and development. With an ISSN of 1071-2690 and an E-ISSN of 1543-706X, this esteemed journal offers a platform for researchers to present their findings and contribute to the body of knowledge necessary for advancements in biological sciences. As a recognized publication, it holds a 2023 category quartile of Q4 in Cell Biology and Developmental Biology, and Q3 in miscellaneous Medicine, reflecting its competitive position yet inviting critical submissions that can span multidisciplinary approaches. Though currently not open access, it serves as an essential resource for professionals, researchers, and students dedicated to unraveling the complexities of cellular processes in an ever-evolving field. The journal has been continuously published since 1986, signifying its long-standing commitment to fostering scientific discourse and innovation.

CELL TRANSPLANTATION

Exploring the future of cell and tissue therapies.
Publisher: SAGE PUBLICATIONS INCISSN: 0963-6897Frequency: 1 issue/year

CELL TRANSPLANTATION is a premier multidisciplinary journal dedicated to advancing the field of regenerative medicine and transplantation, published by SAGE PUBLICATIONS INC. Since its initiation in 1992 and embracing an open-access model since 2017, the journal aims to disseminate high-quality research that covers both clinical and experimental studies on cell and tissue transplantation. With a notable impact reflected in its 2023 Q2 ranking in Biomedical Engineering and significant standings in Cell Biology and Transplantation, CELL TRANSPLANTATION serves as a vital resource for researchers, practitioners, and students alike. The journal's commitment to fostering innovation is evident in its diverse contributions that address the complexities of tissue engineering, immunology, and regenerative therapies, inviting readers to engage with cutting-edge science that is poised to transform medical practices and improve patient outcomes. The journal's insightful articles and research findings make it a crucial platform for knowledge exchange within the vibrant scientific community.

DEVELOPMENTAL CELL

Connecting Researchers with Cutting-Edge Science
Publisher: CELL PRESSISSN: 1534-5807Frequency: 12 issues/year

DEVELOPMENTAL CELL, published by CELL PRESS, stands as a premier journal in the fields of Biochemistry, Genetics and Molecular Biology, Cell Biology, and Developmental Biology. With a significant influence evidenced by its Q1 rankings across several categories in 2023 and a remarkable Scopus ranking placing it at the 98th percentile for Developmental Biology, this journal is pivotal for researchers and academics aiming to advance their understanding of cellular processes. Covering a broad range of topics from molecular mechanisms to cellular developmental pathways, DEVELOPMENTAL CELL publishes cutting-edge research articles that contribute to the dynamic landscape of cell biology and related disciplines. Although it does not currently offer open access, the journal is accessible through institutional subscriptions, reinforcing its commitment to disseminating high-quality scientific knowledge produced by leading experts in the field. Based in the United States, DEVELOPMENTAL CELL continues to push the boundaries of discovery and innovation in life sciences, making it an essential resource for professionals, researchers, and students alike in the quest for foundational biological insights.